A technical note to prevent superficial tumor cell dissemination at fungating soft tissue tumor resection

Ewald Musser1, Maria Smolle1, Jörg Friesenbichler1

  • 1Department of Orthopaedics and Trauma, Medical University of Graz, Auenbruggerplatz 5, A-8036 Graz, Austria.

Insights

This study introduces a novel technique using swabs and incise drapes to cover fungating tumors during resection, preventing tumor spillage. This method achieved excellent intraoperative local control in all eight patients, reducing recurrence risk.

Area of Science:

  • Surgical Oncology
  • Oncologic Surgery

Background:

  • Tumor dissemination within the surgical field heightens the risk of local recurrence.
  • Fungating soft tissue tumors pose a significant contamination risk during wide resection attempts.

Purpose of the Study:

  • To evaluate a novel technique for covering fungating tumors during resection to prevent intraoperative tumor spilling and superficial dissemination.
  • To assess the efficacy of tumor coverage in achieving local tumor control and reducing recurrence risk.

Main Methods:

  • A technique involving swabs to absorb secretions and incise drapes to seal the tumor was employed.
  • Double-row skin staples were used to secure the drapes, preventing dislodgement.
  • The method was applied in eight patients undergoing wide resection for various soft tissue tumors.

Main Results:

  • No intraoperative or postoperative complications were observed with the tumor covering technique.
  • Histological confirmation demonstrated effective intraoperative local control in all eight patients.
  • The technique successfully prevented tumor spilling and superficial dissemination in the surgical field.

Conclusions:

  • Tumor covering during resection is a valuable strategy for enhancing local tumor control, particularly for fungating tumors.
  • This technique offers a safe and effective method to minimize the risk of tumor dissemination during surgery.
  • Implementing adequate tumor coverage can significantly improve oncologic outcomes by preventing local recurrences.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.7K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.9K